Tenax Therapeutics
TENX
23 hedge funds and large institutions have $25.4M invested in Tenax Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
5% more funds holding
Funds holding: 22 → 23 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $40.1M → $25.4M (-$14.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$466K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$233K |
| 3 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$233K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$77.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Bailard
Foster City,
California
|
-$197K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$77.7K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
26
BlackRock Advisors
Wilmington,
Delaware
| $4K | – | – | – |
|
27
Morgan Stanley
New York
| $4K | – | – | – |
|
|
AIG
28
American International Group
New York
| $3K | – | – | – |
|
|
BJ
29
BlackRock Japan
Tokyo,
Japan
| $3K | – | – | – |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
|
IWMPD
31
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| $1K | – | – | – |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
33
Geode Capital Management
Boston,
Massachusetts
| $186 | – | – | – |
|
|
B
34
Bailard
Foster City,
California
| – | -$197K | -2 | Closed |
|
|
IA
35
IFP Advisors
Tampa,
Florida
| – | -$2K | – | – |
|
TENX Hedge Fund Activity: Q1 2016 in Review
23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2016, worth a combined $25.4M — down 36% from $40.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TENX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, adding an estimated $466K. The largest seller was Bailard, exiting entirely with an estimated $197K sold.
- 23 institutional investors held Tenax Therapeutics (TENX) as of Q1 2016, up from 22 in Q4 2015.
- Funds reported $25.4M of Tenax Therapeutics stock for Q1 2016, down 36% quarter-over-quarter.
- 2 funds opened new Tenax Therapeutics positions in Q1 2016 and 1 closed out, a net change of +1 holder.
- The largest Tenax Therapeutics buyer in Q1 2016 was Armistice Capital, an estimated $466K added.
- The largest Tenax Therapeutics seller in Q1 2016 was Bailard, an estimated $197K sold.
Based on aggregated 13F filings for Q1 2016.